SureTrader
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: bigarow, Value_Investor, beambe, Luna Tic, dipANDrip
Search This Board: 
Last Post: 1/15/2018 2:24:16 PM - Followers: 79 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

SureTrader
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1277  Sticky Note NSPR has finally exploded today though we have Value_Investor 01/08/18 06:38:11 PM
#1438   So, not next week. The shareholder meeting isn't Three2001 01/15/18 02:24:16 PM
#1437   So no r/s or approval but yet it’s Chugit 01/15/18 02:10:04 PM
#1436  Restored First, we are seeking approval for a reverse Value_Investor 01/15/18 02:02:47 PM
#1435   Can you give us the link to the Chugit 01/15/18 10:39:31 AM
#1432   All bet off. Runners123 01/14/18 04:58:26 PM
#1431  Restored I bet $0.10 ~ $0.12 will be the Value_Investor 01/14/18 01:30:11 PM
#1430   No its not all that is nonsense Runners123 01/14/18 01:29:47 PM
#1428  Restored You are right. She is done !!!!!!!!!!!! George1234 01/14/18 11:03:16 AM
#1427   Over 10 million volume on Friday n bounced Chugit 01/14/18 02:38:40 AM
#1426   Look at the chart above after hours. Going Chugit 01/14/18 02:06:29 AM
#1425   r/s if approved by shareholders would be in Chugit 01/14/18 02:03:59 AM
#1424   Last sell of insiders was 2017 August at Chugit 01/14/18 01:48:16 AM
#1423   Did you vote for a r/s. than it Chugit 01/14/18 01:14:35 AM
#1422   r/s already priced in if approved by shareholders Chugit 01/13/18 09:58:52 PM
#1421   Well, that's not going to happen. It appears Three2001 01/13/18 05:13:29 PM
#1419   The coming Huge R/S might crash NSPR back Value_Investor 01/13/18 02:34:08 PM
#1418   I agree Runners123 01/13/18 09:32:33 AM
#1417   EXPONENTIAL GROWTH COMING bigarow 01/13/18 09:23:53 AM
#1416   First, when I took the reigns as CEO, bigarow 01/13/18 09:23:05 AM
#1415   NSPR Last 5 minutes of the day almost bigarow 01/13/18 09:11:44 AM
#1414   NSPR Going up.Read this.https://seekingalpha.com/news/3322055-inspiremd-sees-159 bigarow 01/13/18 09:01:04 AM
#1413   578k bid at .1593 shorts better cover next Chugit 01/12/18 07:41:31 PM
#1412   So 58K out of 10M+ shares traded means Three2001 01/12/18 06:55:08 PM
#1411   Low volume brought it down near the close Chugit 01/12/18 06:54:22 PM
#1410  Restored 58,100 shares dumped at $0.1515 at the market Value_Investor 01/12/18 06:48:43 PM
#1409   Shorts going to cover next week. HUGE BID Chugit 01/12/18 06:45:18 PM
#1408   That is Huge. This is going back to Chugit 01/12/18 06:41:44 PM
#1407   There's at least a 600K bid at .1593 Three2001 01/12/18 06:35:43 PM
#1405  Restored Beware folks here: The institutions ownership of NSPR Value_Investor 01/12/18 06:12:53 PM
#1404   INstitutional holders. RRY JAMES J bigarow 01/12/18 03:18:01 PM
#1403   Next resistance .184 bigarow 01/12/18 03:07:43 PM
#1402   NSPR is at bottom and just starting the recovery. bigarow 01/12/18 02:46:04 PM
#1401   NSPR in retrace mode. bigarow 01/12/18 02:45:02 PM
#1400   NSPR solid company. bigarow 01/12/18 02:44:25 PM
#1399   NSPR Best play for 2018. bigarow 01/12/18 02:22:18 PM
#1398   Looks like the selling is over and people Runners123 01/12/18 01:18:25 PM
#1397  Restored Hopefully the "scare" of a R/S has been bcapps66 01/12/18 11:38:16 AM
#1396  Restored Wow, the "R/S" scare-selling already crashed NSPR down Value_Investor 01/12/18 10:55:47 AM
#1395  Restored The moral of this story is that reverse Captain OnThe Bridge 01/12/18 10:03:31 AM
#1394   It went up to 30 from 12.. that's good. drakos 01/12/18 09:53:35 AM
#1393   NSPR declined to $0.161 (which is below today's Value_Investor 01/11/18 09:16:17 PM
#1392   Im in early bought yesterday .20 But onfirestocks 01/11/18 05:45:41 PM
#1391   Correction to the typo in my last post.... “ dk8 01/11/18 05:18:48 PM
#1390   This is exactly what have mentioned in one dk8 01/11/18 05:17:32 PM
#1389   Wow Half a mil @0.172 Someone is really tired dk8 01/11/18 05:14:01 PM
#1388   If this is a pump and dump, something Runners123 01/11/18 09:01:48 AM
#1386   Just a gap fill. Uptrend is intact. George1234 01/11/18 12:27:27 AM
#1385  Restored R/S is not new. Knowing the O/S, you George1234 01/11/18 12:24:39 AM
#1384   Bounce back tomorrow George1234 01/11/18 12:18:08 AM
#1383   HUGE Bounce after hours. Could close Higher. R/S Chugit 01/10/18 07:06:57 PM
PostSubject